Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002CP5
CNY
10.49
-0.29 (-2.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,024.00
1,067.71
789.90
284.06
251.59
235.40
199.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,024.00
1,067.71
789.90
284.06
251.59
235.40
199.14
Raw Material Cost
299.19
397.15
351.62
203.19
179.51
156.51
124.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
92.72
92.90
66.30
25.44
0.00
0.00
20.24
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.31
4.06
0.53
0.56
2.12
0.75
0.41
Selling and Distribution Expenses
606.86
560.62
362.29
84.97
68.66
61.51
59.98
Other Expenses
-7.40
-6.92
-4.20
-2.07
0.24
0.53
-1.50
Total Expenditure (Excl Depreciation)
928.03
985.56
738.72
293.46
252.74
224.03
190.28
Operating Profit (PBDIT) excl Other Income
96
82.10000000000001
51.2
-9.399999999999999
-1.1
11.399999999999999
8.9
Other Income
9.38
19.14
14.58
5.05
7.15
8.74
5.78
Operating Profit (PBDIT)
145.20
131.04
92.78
18.22
25.32
39.94
31.74
Interest
3.31
4.06
0.53
0.56
2.12
0.75
0.41
Exceptional Items
-0.21
0.00
0.90
0.16
0.13
0.69
0.00
Gross Profit (PBDT)
724.81
670.56
438.28
80.87
72.09
78.88
74.46
Depreciation
38.10
29.96
27.01
22.56
19.50
19.84
17.81
Profit Before Tax
103.59
97.02
66.14
-4.75
3.82
20.03
13.52
Tax
51.68
13.17
17.49
1.55
0.54
4.67
1.24
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
25.80
61.65
38.79
-9.11
1.83
12.78
12.28
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
25.80
61.65
38.79
-9.11
1.83
12.78
12.28
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
26.11
22.20
9.87
2.81
1.45
2.59
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
51.91
83.85
48.65
-6.30
3.28
15.36
12.28
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
662.28
633.71
829.38
720.25
729.36
730.56
720.81
Earnings per share (EPS)
0.09
0.2
0.13
-0.03
0.01
0.04
0.04
Diluted Earnings per share
0.09
0.2
0.13
-0.03
0.01
0.04
0.04
Operating Profit Margin (Excl OI)
9.54%
7.67%
6.48%
-3.31%
-0.53%
4.83%
4.09%
Gross Profit Margin
13.84%
11.89%
11.79%
6.27%
9.27%
16.94%
15.73%
PAT Margin
2.52%
5.77%
4.91%
-3.21%
0.73%
5.43%
6.17%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -4.09% vs 35.17% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -38.14% vs 72.28% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 21.36% vs 43.09% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -19.51% vs 720.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,024.00
0
1,024.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,024.00
0
1,024.00
Raw Material Cost
299.19
0
299.19
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
92.72
0
92.72
Power Cost
0
0
0.00
Manufacturing Expenses
3.31
0
3.31
Selling and Distribution Expenses
606.86
0
606.86
Other Expenses
-7.40
0.00
-7.40
Total Expenditure (Excl Depreciation)
928.03
0
928.03
Operating Profit (PBDIT) excl Other Income
95.97
0.00
95.97
Other Income
9.38
0
9.38
Operating Profit (PBDIT)
145.20
0
145.20
Interest
3.31
0
3.31
Exceptional Items
-0.21
0
-0.21
Gross Profit (PBDT)
724.81
0
724.81
Depreciation
38.10
0
38.10
Profit Before Tax
103.59
0
103.59
Tax
51.68
0
51.68
Provisions and contingencies
0
0
0.00
Profit After Tax
25.80
0
25.80
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
25.80
0
25.80
Share in Profit of Associates
0
0
0.00
Minority Interest
26.11
0
26.11
Other related items
0.00
0.00
0.00
Consolidated Net Profit
51.91
0
51.91
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
662.28
0
662.28
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
9.54%
0%
0.00
9.54%
Gross Profit Margin
13.84%
0%
0.00
13.84%
PAT Margin
2.52%
0%
0.00
2.52%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 102.40 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -4.09% vs 35.17% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 5.19 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -38.14% vs 72.28% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.58 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 21.36% vs 43.09% in Dec 2023

Annual - Interest
Interest 0.33 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -19.51% vs 720.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.54%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023